menu

Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    This discussion is part of a series titled "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia".

  • Educational Information

    This discussion is part of a series titled "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia".

  • Faculty

    Prof. Andrew Coats, MD (Coventry, UK), Clara Bonanad Lozano, MD, PhD (Valencia, Spain), and Aaron Wong, MD (Bridgend, UK)

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    This discussion is part of a series titled "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia".

  • Educational Information

    This discussion is part of a series titled "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia".

  • Faculty

    Prof. Andrew Coats, MD (Coventry, UK), Clara Bonanad Lozano, MD, PhD (Valencia, Spain), and Aaron Wong, MD (Bridgend, UK)

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from AstraZeneca.

Facebook Comments

Schedule18 Jun 2024